All In Biotech

Free tool

FAERS Monitor: Viracept

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020779 or its brand name (Viracept, Nelfinavir Mesylate). Reports on generic versions are filed under their own applications.

Reports

2,091

Serious

1,922

92% of reports

Hospitalization

674

Death reported

110

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug exposure during pregnancy414
  • pain243
  • anxiety236
  • emotional distress236
  • anhedonia210
  • foetal exposure during pregnancy203
  • chronic kidney disease140
  • osteoporosis137
  • anaemia120
  • bone density decreased115
  • premature baby115
  • depression110
  • renal failure100
  • pregnancy96
  • osteopenia91

Reports by year received

View as table
YearReports
2004194
2005209
2006199
2007161
200883
200993
2010209
2011101
201251
201329
201431
201595
201691
201729
201846
2019130
2020145
2021105
202242
202319
20241
20258
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,068 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug exposure during pregnancySignal414124.0113.649,838
anhedoniaSignal21081.071.216,405
osteopeniaSignal9160.749.65,254
pregnancySignal9648.539.84,398
premature babySignal11538.632.34,162
bone density decreasedSignal11537.131.03,989
osteoporosisSignal13733.628.64,297
foetal exposure during pregnancySignal20325.222.14,696
emotional distressSignal23619.617.44,173
chronic kidney diseaseSignal14018.615.82,313
anxietySignal2368.37.41,538
renal failureSignal1007.66.3568
anaemiaSignal1206.35.3538
depressionSignal1104.94.1337
painSignal2434.03.5555

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.